Clinical course of erythema nodosum leprosum: An 11-year cohort study in Hyderabad, India

American Journal of Tropical Medicine and Hygiene

Volumn 74, Issue 5, 2006, Pages 868-879

  Pocaterra, Leonor ^a,b   Jain, Suman ^c   Reddy, Rajgopal ^c   Muzaffarullah, Syed ^c   Torres, Obdulita ^c   Suneetha, Sujai ^c   Lockwood, Diana N J ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

^c LEPRA Society   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CLOFAZIMINE; DAPSONE; MINOCYCLINE; OFLOXACIN; PREDNISOLONE; RIFAMPICIN;

ADULT; ARTICLE; BORDERLINE LEPROSY; COHORT ANALYSIS; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; DRUG DOSE INCREASE; ERYTHEMA NODOSUM LEPROSUM; FEMALE; HUMAN; INDIA; LEPROMATOUS LEPROSY; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PATIENT COMPLIANCE; PREVALENCE; RISK FACTOR; ERYTHEMA NODOSUM; HOSPITALIZATION; MEDICAL RECORD; PATHOLOGY; RETROSPECTIVE STUDY; STATISTICAL MODEL;

BACTERIA (MICROORGANISMS);

ADULT; COHORT STUDIES; ERYTHEMA NODOSUM; FEMALE; HUMANS; INDIA; LEPROSY, BORDERLINE; LEPROSY, LEPROMATOUS; LOGISTIC MODELS; MALE; MEDICAL RECORDS; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 33745046121     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2006.74.868     Document Type: Article

References (17)

1. Bryceson AD, Pfalzgraff RE, 1990. Leprosy. Third edition. Edinburgh: Churchill Livingstone.
2. Wemambu SN, Turk JL, Waters MF, Rees RJ, 1969. Erythema nodosum leprosum: a clinical manifestation of the arthus phenomenon. Lancet 2: 933-935.
3. Sarno EN, Grau GE, Vieira LM, Nery JA, 1991. Serum levels of tumour necrosis factor-alpha and interleukin-1 beta during leprosy reactional states. Clin Exp Immunol 84: 103-108.
4. Waters MF, Rees RJ, Sutherland I, 1967. Chemotherapeutic trials in leprosy. 5. A study of methods used in clinical trials in lepromatous leprosy. Int J Lepr Other Mycobact Dis 35: 311-335.
5. Cellona RV, Fajardo TT Jr, Kim DI, Hah YM, Ramasoota T, Sampattavanich S, Carrillo MP, Abalos RM, de la Cruz EC, Ito T, 1990. Joint chemotherapy trials in lepromatous leprosy conducted in Thailand, the Philippines, and Korea. Int J Lepr Other Mycobact Dis 58: 1-11.
6. Nery JA, Vieira LM, de Matos HJ, Gallo ME, Sarno EN, 1998. Reactional states in multibacillary Hansen disease patients during multidrug therapy. Rev Inst Med Trop Sao Paulo 40: 363-370.
7. Schreuder PA, 1998. The occurrence of reactions and impairments in leprosy: experience in the leprosy control program of three provinces in northeastern Thailand, 1987-1995 [correction of 1978-1995]. II. Reactions. Int J Lepr Other Mycobact Dis 66: 159-169.
8. Becx-Bleumink M, Berhe D, 1992. Occurrence of reactions, their diagnosis and management in leprosy patients treated with multidrug therapy; experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia. Int J Lepr Other Mycobact Dis 60: 173-184.
9. Levy L, Fasal P, Levan NE, Freedman RI, 1973. Treatment of erythema nodosum leprosum with thalidomide. Lancet 2: 324-325.
10. Teo SK, Resztak KE, Scheffler MA, Kook KA, Zeldis JB, Stirling DI, Thomas SD, 2002. Thalidomide in the treatment of leprosy. Microbes Infect 4: 1193-1202.
11. Saunderson P, Gebre S, Byass P, 2000. ENL reactions in the multibacillary cases of the AMFES cohort in central Ethiopia: incidence and risk factors. Lepr Rev 71: 318-324.
12. Chattopadhyay SP, Gupta CM, Bhate RD, Bhate RP, Sreevatsa, 1989. Evaluation of two multidrug regimens in hospitalised multibacillary cases. Indian J Lepr 61: 196-205.
13. Helmy HS, Pearson JM, Waters MF, 1971. Treatment of moderately severe erythema nodosum leprosum with clofazimine - a controlled trial. Lepr Rev 42: 167-177.
14. Expert WHO Committee on Leprosy, 1998. World Health Organ Tech Rep Ser 874: 1-43.
15. Plock H, Leiker DL, 1976. A long term trial with clofazimine in reactive lepromatous leprosy. Lepr Rev 47: 25-34.
16. Lockwood D, Bryceson A, 2003. The return of thalidomide: new uses and renewed concerns-reply. Lepr Rev 74: 290-294.
17. Global leprosy situation, 2005. Wkly Epidemiol Rec 80: 289-295.